Greenwave Technology Solutions

Medical Cannabis Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 6.10
0.00 0.00
0
17.33M
US$ 105.710M
US$ 1.30
0.00 0.00
0
53.94M
US$ 70.120M
US$ 0.07
0.0051 8.37
370,363
612.84M
US$ 40.450M
US$ 0.25
0.00 0.00
0
138.96M
US$ 34.740M
US$ 7.23
0.00 0.00
0
4.50M
US$ 32.540M
US$ 0.71
0.00 0.00
0
44.00M
US$ 31.240M
US$ 0.05
0.00 0.00
0
420.76M
US$ 21.040M
US$ 0.02
-0.002 -11.76
85,625
586.81M
US$ 8.800M
US$ 1.64
0.12 7.89
520,130
5.25M
US$ 8.610M
US$ 0.06
0.005 8.77
38,576
135.93M
US$ 8.430M
US$ 0.01
-0.0002 -1.52
90,000
490.47M
US$ 6.380M
US$ 0.02
0.00 0.00
0
403.26M
US$ 6.090M
US$ 0.03
-0.002 -5.88
267,882
184.26M
US$ 5.900M
US$ 0.03
0.002 7.14
1,000
187.98M
US$ 5.640M
US$ 0.02
0.00 0.00
0
328.70M
US$ 5.030M
US$ 0.02
0.00 0.00
0
163.94M
US$ 4.020M
US$ 0.004
0.00 0.00
0
308.39M
US$ 1.230M
US$ 0.75
0.02 3.23
2.08M
728,289
US$ 546K
US$ 0.0009
0.00 0.00
0
423.36M
US$ 381K
US$ 0.0087
0.00 0.00
0
38.91M
US$ 339K
US$ 0.001
0.00 0.00
0
147.69M
US$ 148K
US$ 0.26
0.00 0.00
0
6,274
US$ 2K
US$ 0.00
-0.0002 -100.00
3.50M
9.96B
US$ -
US$ 0.00
0.00 0.00
0
102.36M
US$ -
US$ 0.00
0.00 0.00
0
407.07M
US$ -
US$ 0.00
0.00 0.00
0
70.39M
US$ -

Medical Cannabis News


WEED Forms Strategic Partnership with Remergify to Design, Develop, Program, Deploy & Coordinate the Launch of WEEDCoin & BUDZCoin in the AI/Crypto/Blockchain Universe

    Remergify Inc., a leading strategic advisory firm specializing in asset monetization and blockchain integration, to use its expertise in blockchain, tokenization and AI expertise to spearhead the tokenization of WEEDs launch into the world of Crypto! TUCSON, ARIZONA / ACCESS Newswire / December 16, 2025 / WEED Inc. ("WEED" or the "Company") is a global cannabis & hemp bioresearch company... Read more


    MediPharm Labs Completes First Shipment to France

      TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the completion of the Company's first shipment to France. This milestone follows a production agreement with an international medicinal cannabis organization.... Read more


      1933 Industries Announces Year End 2025 Financial Results and Reports Positive Income

        VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries")(CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its audited annual financial results for the years ended July 31, 2025 and 2024 ("Fiscal 2025"). All amounts expressed are in Canadian dollars. The Company owns 100% [1] of Alternative Medicine... Read more


        FLUENT Reports Third Quarter 2025 Results

          Focused on Margin Expansion, Operational Efficiency, and Strategic Market Positioning Ahead of Buffalo, New York and Rosa, Florida Premium Indoor Facility Activations in Q4 2025 TAMPA, Fla., Nov. 28, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating... Read more


          FLUENT Cannabis Announces Opening of New Dispensary in Brandon, Florida

            Grand Opening Celebration will be Saturday, November 22, 2025 TAMPA, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced that its new 2,800 sq ft Brandon, FL dispensary is now open for patients, with a grand opening celebration set for Saturday, November 22, 2025. The new store opening reflects FLUENT’s ongoing... Read more


            FLUENT Cannabis Launches Bag-O 7g Ground Flower in Florida, Expanding Patient Choice and Convenience

              TAMPA, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the launch of its new Bag-O 7-gram Ground Flower product line in Florida dispensaries, further strengthening the Company’s portfolio and offering patients more convenient, ready-to-use options for dry herb consumption. The product is grounded in a simple... Read more


              MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains

                Q3 2025 Revenue of $11.4 Million, an Increase of 17% over Q3 2024 83% Growth in Year-Over-Year Revenue for International Medical Cannabis International Medical sales now 56% of Total Revenue Increased Cash Balance of $10.6 Million at the end of Q3 2025 Operating Expenses Decreased 19% Year-Over-Year Management to Host Conference Call / Webcast on November 13th, 2025 at 10:00... Read more


                IM Cannabis Reports Third Quarter 2025 Financial Results

                  TORONTO and GLIL YAM, Israel, Nov. 13, 2025 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the third quarter and nine months ended September 30, 2025. All amounts are reported in Canadian dollars and compared to the quarter and nine months ended September 30, 2024, unless otherwise stated. Q3... Read more


                  CV Sciences Reports Third Quarter 2025 Financial Results

                    SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2025. Third Quarter 2025 and Recent Financial and... Read more


                    Akanda Researching Security Requirements for Full Cultivation License

                      Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") is researching the security requirements and next steps for a full cultivation license through its cannabis operating subsidiary. Recently, the Company extended its option on its British Columbia asset for an additional two years. While the Company currently operates under its hemp cultivation... Read more


                      FLUENT Completes First Harvests at Rosa Facility, Advancing Its Growth Strategy and Proving Operational Execution

                        TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the successful completion of the first series of harvests at Rosa, the company’s newest Florida indoor cultivation facility. The inaugural harvests represent another significant operational milestone as FLUENT continues to expand its premium production capacity... Read more


                        FLUENT Unifies New York Retail Network with Rebranding of Manhattan and White Plains Dispensaries

                          NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the rebranding of its Manhattan and White Plains dispensaries, marking the second and third adult-use locations in New York to officially transition under the FLUENT banner. The White Plains and Manhattan rebrands follow FLUENT’s acquisition of RIV Capital on... Read more


                          Akanda Increasing Its Cannabis Investment

                            Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), through its cannabis operating subsidiary, has furthered its cannabis investment by extending its option on its British Columbia asset for two additional years. The Company has been working on obtaining its full cultivation license for a variety of potential products containing THC, but... Read more


                            Innocan Pharma: Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan

                              Innovative Chronic Pain Treatment Receives allowance for IP Protection in Japan's World Third Largest Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, Oct. 15, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its patent for LPT-CBD... Read more


                              PharmaCielo Completes La Margarita Land Sale, Repays Banco Agrario Loan, Strengthens Balance Sheet, Completes Audit

                                TORONTO and RIONEGRO, Colombia, Oct. 06, 2025 (GLOBE NEWSWIRE) -- PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTC: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced the closing of the sale of its La Margarita property in Carmen de Viboral,... Read more


                                Akanda's First Towers and Fiber Taps Into Mexico's $7 Billion Telecom Buildout

                                  TORONTO, ON / ACCESS Newswire / October 1, 2025 / Scarcity is usually a problem in business. For Akanda Corp. (NASDAQ:AKAN), it's an advantage. The company sits on one of the leanest floats on the Nasdaq, barely 728,000 shares after its reverse split. That scarcity means every contract, every tower, and every stretch of fiber deployed carries more weight than it would anywhere else. First Towers... Read more


                                  Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio...

                                    NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray Craft portfolio in Germany... Read more


                                    Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection

                                      HERZLIYA, Israel and CALGARY, AB, Sept. 18, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce its ongoing collaboration with Freedom Farm, a sanctuary dedicated to rescuing animals that were expelled from the industrial farms as a result of the animals having... Read more


                                      Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains

                                        Tilray Affirms Continued Commitment to German Healthcare and Expanding Patient and Pharmacy Access in Europe's Largest Medical Cannabis Market LONDON and NEUMÜNSTER, Germany, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients... Read more


                                        FLUENT Reports Second Quarter 2025 Results

                                          TAMPA, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) --  FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the second quarter ended June 30, 2025. Unless otherwise indicated, all financial results are presented in U.S. dollars. Management Commentary “While Q2 results... Read more


                                          Body and Mind Announces Agreement to Divest from New Jersey

                                            Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - August 25, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC: BMMJ) (the "Company" or "BaM") is pleased to announce the Company's wholly owned subsidiary, DEP Nevada, Inc. ("DEP") has entered into a Purchase Agreement with Ascend New Jersey, LLC (the "Purchaser"), whereby DEP, which owns 100% of BaM Body and Mind Dispensary NJ, Inc. ("BAM... Read more


                                            FLUENT Announces Exclusive Cultivation Partnership with Connected Cannabis at New Facility in Buffalo, New York

                                              Connected brands, including Connected Cannabis, AlienLabs and Smoken Promises branded products, to be distributed through the ENTOURAGE wholesale network and FLUENT retail stores NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the commencement of operations at its new 68,000+ square-foot indoor cultivation... Read more


                                              High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH

                                                Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across... Read more


                                                MediPharm Labs Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis

                                                  Q2 Revenue of $11.8 Million, an Increase of 14% over Q2 2024 50% Growth in Revenue for International Medical Cannabis International Medical sales now 57% of Total Revenue Cash Balance of $10.4 Million at the end of Q2, Increased from $8.4 Million in Q1 2025 Management to Host Conference Call / Webcast on August 14th, 2025 at 10:00 am ET TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE)... Read more


                                                  Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts

                                                    Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed... Read more


                                                    MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States

                                                      MediPharm Labs holds unique US Food and Drug Administration (FDA) site registration in relation to the manufacturing and release of pharmaceutical cannabis products.   MediPharm is the only US FDA Audited purpose-built commercial cannabis facility in Canada. One of a handful globally. The possible rescheduling of cannabis in the US opens new opportunities for MediPharm in categories... Read more


                                                      CV Sciences Reports Second Quarter 2025 Financial Results

                                                        SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2025. Second Quarter 2025 and Recent Financial and Operating... Read more


                                                        IM Cannabis Reports Second Quarter 2025 Financial Results

                                                          IMC Delivers Strong Profit and Margin Growth Despite Revenue Impact from External Challenges in Q2 2025 TORONTO and GLIL YAM, Israel, Aug. 12, 2025 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2025. All amounts are reported in Canadian dollars and compared... Read more


                                                          IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million

                                                            TORONTO and GLIL YAM, Israel, July 31, 2025 /CNW/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, effective July 30, 2025 (the "Closing Date") it has closed a private placement offering (the "Offering"), through the issuance of 2,050,000 units (each a "Unit") at a price... Read more


                                                            MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler

                                                              TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specializing in precision-based cannabinoids, is pleased to announce it has launched the new Shake & Puff CBN THC Nighttime Inhaler in Canada. This innovative product expands MediPharm’s leading CBN oil product portfolio... Read more

                                                              COPYRIGHT ©2025 GREEN STOCK NEWS